The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

NCT05042128 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

158

Enrollment

NETWORK

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Cancer

Interventions

DRUG: LSTA1
DRUG: Gemcitabine Injection
DRUG: Nab paclitaxel

Sponsor

Australasian Gastro-Intestinal Trials Group

Collaborators

[object Object]